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Deletion of the Neurotrophic 
Factor neudesin Prevents Diet-
induced Obesity by Increased 
Sympathetic Activity
Hiroya Ohta1, Morichika Konishi1, 2, Yusuke Kobayashi1, Atsuki Kashio1, 
Takayuki Mochiyama1, Shigenobu Matsumura3, Kazuo Inoue3, Tohru Fushiki3, 
Kazuwa Nakao4, Ikuo Kimura5, 6 & Nobuyuki Itoh1
Some neurotrophic factors, which are potent regulators of neuronal development and function, 
have recently been implicated in the control of energy balance by increasing energy expenditure. 
We previously identified neudesin as a novel neurotrophic factor with potential roles in the central 
nervous system. Although neudesin is also expressed in various peripheral tissues including adipose 
tissue, its physiological roles have not yet been elucidated. We found that neudesin knockout (KO) 
mice were resistant to high-fat diet-induced obesity and obesity-related metabolic dysfunctions. 
neudesin KO mice exhibited increased energy expenditure due to increased sympathetic activity, 
which resulted in increased heat production and fatty acid oxidation in brown adipose tissue and 
enhanced lipolysis in white adipose tissue. Thus, neudesin, which may be a negative regulator of 
sympathetic activity, could represent a novel regulator of the development of obesity and obesity-
related metabolic dysfunctions.
The epidemic of obesity is closely associated with an increase in metabolic disorders, including diabetes, 
dyslipidemia, and cardiovascular diseases1–3, and has, thus, propelled major interest in the regulation of 
adipose functions. Adipose tissue can be divided into two distinct types: white and brown. White adi-
pose tissue (WAT) is specialized for the storage of excess energy as triglycerides (TG)4, whereas brown 
adipose tissue (BAT) dissipates energy as heat, thereby counteracting obesity5. The sympathetic nervous 
system (SNS) plays fundamental roles in maintaining energy homeostasis in living organisms6. The SNS 
is essential for regulating adipose function and the development of obesity because it stimulates lipolysis 
in WAT and enhances heat production in BAT by activating adrenergic signaling7–9.
Neurotrophic factors promote the survival, differentiation, and maintenance of neurons in the verte-
brate nervous system and are crucial for nervous system functions10–12. Some neurotrophic factors have 
recently been recognized as crucial regulators of energy metabolism13,14. For example, the administration 
of brain-derived neurotrophic factor (BDNF) was shown to increase energy expenditure15, and Bdnf 
heterozygous mice exhibited obesity phenotypes16. The administration of ciliary neurotrophic factor, 
another neurotrophic factor, suppressed adiposity, hyperphagia, and hyperinsulinemia in ob/ob mice17. 
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Thus, neurotrophic factors generally induce anti-obesity effects by suppressing food intake or increasing 
energy expenditure.
We previously identified the neurotrophic factor, neudesin, which was well conserved in various verte-
brates, including humans, mice, and zebrafish18–20. Previous studies reported that neudesin was expressed 
in the brain and spinal cord of embryonic mice and appears to be essential for neuronal function18–22. The 
administration of recombinant neudesin to the hypothalamus was reported to repress appetite24. Novais 
et al. generated neudesin KO mice and showed that the neudesin deletion resulted in shorter dendrites in 
the dentate gyrus of the hippocampus and increased anxious-like behaviors25. This is the first and only 
study that described the physiological role of neudesin in the central nervous system (CNS); however, 
its systemic roles are not yet fully understood. neudesin was also expressed in various peripheral tissues 
in adult mice, including adipose tissue, and several studies suggested that it may play roles in peripheral 
tissues19,20,23. Thus, determining the system effects of neudesin in various tissues is essential for eluci-
dating its physiological effects. Therefore, we also generated neudesin KO mice that were resistant to 
high-fat diet (HFD)-induced obesity and obesity-related metabolic dysfunctions. The present findings 
represent the first report that a neurotrophic factor suppresses energy expenditure. neudesin, which may 
be a negative regulator of sympathetic activity, could represent a novel regulator of the development of 
obesity and obesity-related metabolic dysfunctions.
Results
neudesin KO mice were resistant to diet-induced obesity. neudesin was previously reported to 
be expressed in the CNS and various peripheral tissues of adult mice18–20,23 (Fig. S1A). We generated 
neudesin KO mice to elucidate its physiological roles. neudesin KO mice showed the expected Mendelian 
ratios (Fig. S1B-G) and were apparently normal and fertile. We then examined the body weights and 
tissue weights of WT and neudesin KO mice. Body weights at 8 weeks of age and E18.5 were similar 
between wild type (WT) and neudesin KO mice. The weights of principal tissues including the liver, 
heart and kidney but not WAT at 8 weeks of age were also similar between WT and neudesin KO mice 
(Fig. 1A, Fig. S2 and Table. S1). Tibia lengths, which reflected growth26, were also similar between WT 
and neudesin KO mice (Fig. S1H). These results suggested that the growth of neudesin KO mice was 
essentially normal. However, increases in body weight were suppressed in neudesin KO mice as they 
grew, and at 16 weeks of age, their body weights were lower than those of WT mice. Increases in body 
weights due to HFD in WT mice were strongly suppressed in neudesin KO mice (Fig. 1A).
We measured the weights of various tissues at 16 weeks of age and the obtained results were summa-
rized in Table 1. The WAT weight was significantly lower in neudesin KO mice than in WT mice when 
they were fed normal chow (NC). When WT mice were fed HFD, WAT weight was greater than when 
fed NC, whereas this increase was strongly suppressed in neudesin KO mice (Table 1). We next examined 
the morphology of white adipocytes (Fig. 1B). The sizes of white adipocytes in neudesin KO mice fed NC 
were not significantly different from those in WT mice fed NC. HFD caused adipocyte hypertrophy in 
WT mice, which was significantly suppressed in neudesin KO mice (Fig. 1C).
The weights of the liver and BAT were similar between WT and neudesin KO mice when they were 
fed NC (Table  1). Increases were observed in the weights of the liver and BAT of WT mice fed HFD, 
whereas these increases were significantly less in neudesin KO mice fed HFD. We then histologically 
examined the liver and BAT of WT and neudesin KO mice (Fig. 1D,E). The liver was apparently normal 
in both WT and neudesin KO mice fed NC, whereas the marked accumulation of lipids was observed in 
WT mice fed HFD. However, HFD-induced lipid accumulation in the liver was significantly decreased 
in neudesin KO mice (Fig. 1D). BAT was also apparently normal in both WT and neudesin KO mice fed 
NC, whereas the formation of large lipid droplets was observed in WT mice fed HFD. The formation 
of lipid droplets was suppressed in neudesin KO mice (Fig. 1E). The weights of other tissues examined 
were similar between WT and neudesin KO mice. These results suggested that neudesin KO mice were 
resistant to diet-induced obesity (DIO).
neudesin KO mice were protected from obesity-induced metabolic dysfunctions. We meas-
ured various metabolic parameters and the results were summarized in Table  2. The levels of glucose, 
total cholesterol, and leptin were significantly increased in WT mice fed HFD, and this increase in met-
abolic parameters was generally suppressed in neudesin KO mice fed HFD. These results suggested that 
neudesin KO mice were protected from obesity-induced metabolic dysfunctions.
Obesity is known to cause insulin resistance. Blood glucose and plasma insulin levels were similar 
between WT and neudesin KO mice when fed NC (Table  2). WT mice showed increased glucose and 
insulin levels when fed HFD, whereas this HFD-induced increase in glucose and insulin levels was sup-
pressed in neudesin KO mice (Table  2). These results indicated that neudesin KO mice were protected 
from insulin resistance. We then performed glucose tolerance and insulin tolerance tests. Glucose toler-
ance in WT mice was impaired by HFD and this effect was significantly improved in neudesin KO mice 
(Fig. 2A,B). In parallel, insulin sensitivity was aggravated in WT mice fed HFD, but was also significantly 
improved in neudesin KO mice (Fig.  2C,D). These results suggested that neudesin KO mice were pro-
tected from HFD-induced insulin resistance.
Obesity can also induce the infiltration of macrophages to adipose tissue, which causes inflammation. 
We examined the expression levels of F4/80, a macrophage marker27. The expression levels of F4/80 in 
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WT mice fed HFD were significantly higher in mesenteric WAT and tended to be higher in subcutane-
ous WAT compared with those in WT mice fed NC. However, its expression levels in neudesin KO mice 
fed HFD were not significantly but tended to be lower than those in WT mice fed HFD (Fig. 2E). Thus, 
neudesin KO mice might be protected from obesity-induced inflammation.
Figure 1. neudesin KO mice were resistant to diet-induced obesity (a): Body weight changes in wild 
type (WT) and neudesin knockout (KO) mice fed normal chow (NC) or high-fat diet (HFD). All mice 
were weighed weekly (n = 6–14; *, p < 0.05, ***, p < 0.001 vs. WT within the same condition. #, p < 0.05, 
##, p < 0.01, ###, p < 0.001 vs. feeding within the same genotype). (b) Paraffin sections of mesenteric white 
adipose tissue (mesWAT) and subcutaneous WAT (subWAT) from WT and neudesin KO mice at 16 weeks 
of age were stained with hematoxylin and eosin. Scale bar, 100 μm. (c) The adipocyte areas of WT and 
neudesin KO mice at 16 weeks of age. The average adipocyte cell areas were measured using at least 100 
cells per mouse (n = 3–5; *, p < 0.05; ***, p < 0.001). (d) Frozen sections of the liver of WT and neudesin KO 
mice fed a NC or HFD at 16 weeks of age were stained with hematoxylin and eosin. Scale bar, 100 μm. 
(e) Paraffin sections of brown adipose tissue (BAT) of WT and neudesin KO mice at 16 weeks of age were 
stained with hematoxylin and eosin. Scale bar, 100 μm.
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Energy expenditure was increased in neudesin KO mice. We found that neudesin KO mice were 
resistant to DIO and obesity-induced metabolic dysfunctions including diabetes. We attempted to elu-
cidate why neudesin KO mice were resistant to DIO. Food intake at 16 weeks of age was slightly but 
significantly lower in neudesin KO mice than in WT mice fed NC, whereas food intake at 16 weeks of 
age was similar between WT and neudesin KO mice fed HFD (Fig. S3A). Thus, resistance to DIO was 
independent of food intake. We estimated fat absorption by determining fecal weights and fecal TG 
contents and found that more than 99% TG in HFD was absorbed in both WT and neudesin KO mice 
(Fig. S3B). Thus, the deletion of neudesin had little effect on fat absorption.
The enhancement observed in energy expenditure could have induced resistance to DIO. The rectal 
temperature of neudesin KO mice fed HFD was significantly higher than that of WT mice fed HFD, 
although voluntary activity was similar between WT and neudesin KO mice (Fig.  3A,B). Respiratory 
gas analysis showed that oxygen consumption was significantly increased in neudesin KO mice fed HFD 
(Fig.  3C). The respiratory quotient was significantly lower in neudesin KO mice fed HFD than in WT 
mice (Fig. 3D). Fatty acid oxidation was significantly increased in neudesin KO mice fed HFD (Fig. 3E). 
Carbohydrate oxidation was similar between WT mice and neudesin KO mice (Fig.  3F). These results 
indicated that energy expenditure in neudesin KO mice fed HFD was increased, which contributed to 
the observed resistance to DIO.
Sympathetic activity was increased in neudesin KO mice. We attempted to elucidate why 
energy expenditure in neudesin KO mice was increased. As increased sympathetic activity often results 
in increased energy expenditure6,28, we examined the effects of the neudesin deletion on sympathetic 
activity. Heart rate, which is a common indicator of sympathetic activity29, was significantly increased in 
neudesin KO mice (Fig. 4A).
We next measured catecholamine levels in BAT and WAT, which also reflected sympathetic activity30. 
Norepinephrine levels were essentially similar in BAT and WAT of neudesin KO mice fed NC, whereas 
norepinephrine levels were significantly higher in BAT and tended to be higher in WAT of neudesin KO 
mice fed HFD (Fig. 4B,C). Norepinephrine levels in plasma were also significantly increased in neudesin 
KO mice fed NC and HFD (Fig. 4D). These results suggested that sympathetic activity was increased in 
neudesin KO mice fed HFD. In addition, we found that recombinant neudesin suppressed the expression 
WT NC KO NC WT HFD KO HFD
mesenteric WAT (mg) 351.2 ± 29.6 204.3 ± 10.5 * 947.9 ± 160.4 # 303.4 ± 40.1 **
subcutaneous WAT (mg) 606.7 ± 60.8 390.6 ± 26.6 2022.4 ± 199.4 ### 792.9 ± 94.4 ***
epididymal WAT (mg) 715.8 ± 71.7 441.1 ± 39.5 2218.7 ± 101.6 ###
964.5 ± 116.6 
##, ***
BAT (mg) 86.0 ± 8.3 63.7 ± 6.5 155.8 ± 19.7 ## 99.2 ± 7.7 **
Liver (mg) 1198.5 ± 75.1 1095.3 ± 23.3 1422.6 ± 109.8 1001.9 ± 39.4 ***
Heart (mg) 132.7 ± 6.5 117.5 ± 4.0 137.2 ± 4.3 127.3 ± 3.8
Kidney (mg) 176.7 ± 6.0 155.6 ± 3.3 161.9 ± 4.6 155.2 ± 4.6
Spleen (mg) 69.2 ± 4.3 61.8 ± 5.5 120.2 ± 34.5 161.5 ± 23.2
Table 1. Tissue weights of WT and neudesin KO mice fed NC and HFD at 16 weeks of age. Data are 
means ± standard error of means (SEMs) (n = 4–11. * p < 0.05, ** p < 0.01, *** p < 0.001, vs WT mice within 
the same condition. #, p < 0.05, ##, p < 0.01, ###, p < 0.001 vs. feeding within the same genotype).
WT NC KO NC WT HFD KO HFD
Glucose (mg/dl) 126.5 ± 7.4 112.0 ± 5.1 168.1 ± 7.4 # 135.2 ± 7.6 *
Insulin (ng/ml) 1.39 ± 0.20 0.95 ± 0.30 3.45 ± 0.51 0.79 ± 0.16 **
TG (mg/dl) 88.1 ± 10.4 74.5 ± 2.3 93.5 ± 5.5 60.2 ± 8.7
NEFA (mEq/L) 0.358 ± 0.032 0.365 ± 0.015 0.419 ± 0.019 0.293 ± 0.017 **
Total cholesterol (mg/dl) 69.6 ± 7.9 67.3 ± 5.7 231.3 ± 7.4 ### 153.0 ± 16.6 ###, **
Leptin (ng/ml) 1.6 ± 0.3 1.1 ± 0.2 28.7 ± 1.0 ### 14.5 ± 2.1 ###, ***
Table 2. Metabolic parameters of WT and neudesin KO mice at 16 weeks of age. Data are 
means ± standard error of means (SEMs) (n = 4–9; *, p < 0.05, **, p < 0.01, ***, p < 0.001, vs WT mice within 
the same condition. #, p < 0.05, ###, p < 0.001 vs. feeding within the same genotype)
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levels of tyrosine hydroxylase (Th), which encodes a rate-limiting enzyme in the synthesis of norepi-
nephrine, in differentiated PC12 cells, which show sympathetic neuron-like properties31 (Fig. 4E). Thus, 
neudesin may suppress sympathetic activity by reducing Th expression.
Enhanced sympathetic activity has been shown to stimulate β3-adrenergic receptors (β3AR) in adi-
pose tissue7, increase heat production and fatty acid oxidation in BAT9, and promote lipolysis in WAT8. 
We then examined the physiological effect of this enhanced sympathetic activity on BAT and WAT. 
We firstly examined the expression levels of Ucp1, Cpt1, Pparα, and Pgc-1α in BAT. Ucp1 is expressed 
exclusively in BAT and is indispensible for thermogenesis. CPT1 catalyzes the entry of fatty acids into 
mitochondria and is crucial for fatty acid oxidation. PPARα and PGC-1α are the transcriptional regula-
tors of thermogenesis and fatty acid oxidation. The expression levels of Ucp1, Cpt1, Pparα, and Pgc-1α in 
BAT of neudesin KO mice at 4 and 16 weeks of age fed NC were similar to those in WT a mice (Fig. 5A 
and Fig. S4). However, these expression levels in BAT of neudesin KO mice at 16 weeks fed HFD were 
significantly higher than those in WT mice (Fig.  5A). We examined the expression levels of β3AR in 
BAT. Its levels in WT mice fed HFD were significantly lower than those in WT mice fed NC. However, 
its levels in neudesin KO mice fed HFD were similar to those in neudesin KO mice fed NC but signifi-
cantly higher than those in WT mice fed HFD (Fig. 5B). The lipolytic activity of subcutaneous WAT in 
neudesin KO mice increased slightly when they were fed NC and increased markedly when they were 
fed HFD (Fig. 5C). These results indicated that sympathetic activity was increased in adipose tissue of 
neudesin KO mice. Thus, the energy expenditure was increased by the increased sympathetic activity 
in WAT and BAT of neudesin KO mice, resulting in the resistance to DIO. The hypothalamus greatly 
contributes to the regulation of sympathetic activity, and several neuropeptides including POMC, NPY, 
AGRP, BDNF, and CRF in the hypothalamus are the important regulators of sympathetic activity and 
affect the development of obesity32–34. To examine the roles of the neuropeptides in the hypothalamus in 
increased sympathetic activity in neudesin KO mice fed HFD, we examined the expression levels of Pomc, 
Npy, Agrp, Bdnf, and Crf in the hypothalamus. Their expression levels in neudesin KO mice fed HFD were 
Figure 2. neudesin KO mice were resistant to obesity-induced metabolic dysfunctions (a): The results 
of the glucose tolerance test (GTT) on WT mice and neudesin KO mice fed NC or HFD at 16 weeks of age 
(n = 6–7; **, p < 0.01 vs. WT within the same condition. #, p < 0.05, ##, p < 0.01, ###, p < 0.001, vs. feeding 
within the same genotype). The blood glucose levels at an initial point were 114.3 ± 6.5 mg/dl for WT NC, 
111.3 ± 9.1 mg/dl for KO NC, 157.3 ± 7.1 mg/dl for WT HFD and 137.8 ± 15.0 mg/dl for KO HFD. (b) The 
average area under the blood glucose curve (AUC) for GTT (n = 6–7; *, p < 0.05, ***, p < 0.001). (c) The 
results of the insulin tolerance test (ITT) on WT and neudesin KO mice fed NC or HFD at 16 weeks of age 
(n = 3–7; *, p < 0.05, **, p < 0.01 vs. WT within the same condition. #, p < 0.05, ##, p < 0.01, ###, p < 0.001, vs. 
feeding within the same genotype). The blood glucose levels at an initial point were 111.1 ± 8.5 mg/dl for 
WT NC, 107.3 ± 9.8 mg/dl for KO NC, 184.0 ± 17.2 mg/dl for WT HFD and 145.8 ± 11.5 mg/dl for KO HFD. 
(d) The average area under the blood glucose curve (AUC) for ITT (n = 3–7; *, p < 0.05, **, p < 0.01). (e) The 
expression levels of F4/80 in mesenteric WAT and subcutaneous WAT of WT and neudesin KO mice fed a 
NC or HFD at 16 weeks of age. 18S rRNA levels were used as an internal control and expression levels in 
WT mice fed NC were taken as 1.0 (n = 3–5; *, p < 0.05).
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Figure 3. neudesin KO mice showed a systemic increase in energy expenditure (a): Body temperature of 
WT and neudesin KO mice at 16 weeks of age (n = 4–6; *, p < 0.05). (b) The voluntary activity of WT and 
neudesin KO mice fed HFD at 12 weeks of age (WT: n = 3, KO: n = 4). Respiratory gas analysis performed on 
WT and neudesin KO mice at 12 weeks of age fed NC or HFD (n = 4–8; *, p < 0.05). (c) Oxygen consumption 
by WT and neudesin KO mice at 12 weeks of age. (d) The respiratory quotient (RQ) of WT and neudesin 
KO mice at 12 weeks of age. RQ was calculated based on O2 consumption and CO2 production. (e) Fatty 
acid oxidation by WT and neudesin KO mice at 12 weeks of age. (f) Carbohydrate oxidation by WT and 
neudesin KO mice at 12 weeks of age.
www.nature.com/scientificreports/
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Figure 4. neudesin KO mice showed increased sympathetic activity (a): The heart rates of WT and 
neudesin KO mice at 16 weeks of age (n = 4–6; *, p < 0.05; **, p < 0.01). (b) Norepinephrine levels in 
BAT of WT and neudesin KO mice at 16 weeks of age (n = 3–5; *, p < 0.05). (c) Norepinephrine levels 
in subcutaneous WAT of WT and neudesin KO mice at 16 weeks of age (n = 3–5). (d) Plasma levels of 
norepinephrine in WT and neudesin KO mice at 16 weeks of age (n = 4–5; *, p < 0.05). (e) The expression 
levels of tyrosine hydroxylase (Th) in differentiated PC12 cells (n = 5–6; *. p < 0.05). 18S rRNA levels were 
used as an internal control and expression levels in cells without NGF and recombinant neudesin were taken 
as 1.0.
www.nature.com/scientificreports/
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essentially comparable to those in WT mice (Fig. S5). The results suggest that these neuropeptides did 
not contribute to the increased sympathetic activity observed in neudesin KO mice fed HFD.
Discussion
In the present study, we generated neudesin KO mice to elucidate its physiological roles. The results 
obtained showed that neudesin KO mice were resistant to DIO and obesity-related metabolic dysfunc-
tions. Energy expenditure in neudesin KO mice was increased by increased sympathetic activity. Thus, 
neudesin appeared to be a suppressor of energy metabolism in vivo.
neudesin was originally identified as a neurotrophic factor. Neurotrophic factors promote the sur-
vival, differentiation, and maintenance of neurons in the nervous system. Previous studies suggested that 
neudesin was expressed in the CNS and required for CNS functions and development18–22,24,25. For exam-
ple, Novais et al. reported that neudesin KO mice exhibited increased anxious-like behaviors caused by 
shorter dendrites in the dentate gyrus of the hippocampus25. Byerly et al. also reported that neudesin was 
expressed in the paraventricular nuclei (PVN) and arcuate nucleus (ARC), which are important areas of 
the hypothalamus for regulating appetite35,36, and that the administration of recombinant neudesin into 
the hypothalamus repressed appetite24. However, we showed that food intake by neudesin KO mice fed 
NC was decreased, suggesting that neudesin increases food intake. This discrepancy may be explained 
by differences in the physiological analysis using neudesin KO mice and pharmacological analysis by 
the administration of recombinant neudesin. In contrast, as food intake was similar between WT and 
neudesin KO mice when fed HFD, resistance to DIO in neudesin KO mice was independent of food 
intake. Resistance to DIO in neudesin KO mice may be mediated by increased sympathetic activity. PVN 
and ARC also regulate energy expenditure by affecting sympathetic activity37,38. However, our results 
showed that the expression levels of hypothalamic neuropeptides, which are the important regulators 
of sympathetic activity and affect the development of obesity32–34, in neudesin KO mice fed HFD were 
similar to those in WT mice. Thus, increased sympathetic activity observed in neudesin KO mice fed 
Figure 5. neudesin KO mice showed enhanced energy expenditure in BAT and WAT (a): The expression 
levels of Ucp1, Pgc-1α, Pparα, and Cpt1b in the BAT of WT and neudesin KO mice at 16 weeks of age. 18S 
rRNA levels were used as an internal control and expression levels in WT mice fed NC were taken as 1.0 
(n = 5–7; *, p < 0.05; **, p < 0.01). (b) The expression levels of β3AR in the BAT of WT and neudesin KO mice 
at 16 weeks of age. 18 S rRNA levels were used as an internal control and expression levels in WT mice fed 
NC were taken as 1.0 (n = 5–7; *, p < 0.05, ***, p < 0.001). (c) Lipolytic activity in the subcutaneous WAT of 
WT and neudesin KO mice at 16 weeks of age. Lipolytic activity was standardized to that of WT mice fed 
NC and the lipolytic activity of WT mice fed NC was taken as 1.0 (n = 3–4; *, p < 0.05).
www.nature.com/scientificreports/
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HFD may not be mediated by hypothalamic regulation in the CNS. We found that recombinant neudesin 
might suppress Th expression in differentiated PC12 cells with sympathetic neuron-like properties31. 
Additionally, neudesin KO mice exhibited increased levels of norepinephrine in adipose tissue, which are 
good indicators of sympathetic activity30. Thus, peripheral neudesin may suppress sympathetic activity 
by suppressing Th expression in peripheral neurons. However, further studies are required to elucidate 
the roles of central and peripheral neudesin in regulating sympathetic activity.
neudesin was shown to be expressed in various peripheral tissues, including WAT and BAT. We could 
not detect neudesin in plasma (unpublished observation), indicating that it is a local signaling molecule 
in peripheral tissues. neudesin is expected to act on targeted cells through a specific neudesin receptor, 
which has not yet been identified18–23. neudesin in adipose tissue may suppress sympathetic activity by 
activating the neudesin receptor expressed in peripheral neurons in or near adipose tissue. The expres-
sion levels of neudesin in WAT were significantly increased in WT mice fed HFD, whereas its expression 
in BAT was essentially unchanged (Fig. S6). However, the precise mechanism underlying the increase in 
sympathetic activity in neudesin KO mice remains unknown. Further studies are required to elucidate the 
roles of neudesin in regulating sympathetic activity. Additionally, previous studies suggested that neu-
desin could act on non-neuronal cells besides neurons23,39. Thus, some of the functions of neudesin could 
not be explained by its neurotrophic factor properties. We need to examine the role of neudesin other 
than as a neurotrophic factor in the future to obtain a better understanding of its physiological roles.
Although neurotrophic factors generally increase energy expenditure, neudesin suppresses it. To 
the best of our knowledge, this is the first study to show that a neurotrophic factor suppresses energy 
expenditure. Thus, the present study may shed new light on the physiological roles of neurotrophic fac-
tors in energy metabolism. In conclusion, we showed that neudesin was a possible regulator of energy 
expenditure and may contribute to the development of obesity. neudesin KO mice were resistant to 
DIO and obesity-related metabolic dysfunctions, and exhibited increased energy expenditure. Increased 
energy expenditure was attributed to a systemic increase in sympathetic activity. Our results suggested 
the physiological importance of neudesin in regulating energy expenditure and its role as a suppressor 
of sympathetic activity. We expect that neudesin could represent a novel regulator of the development of 
obesity and obesity-related metabolic dysfunctions.
Methods
Gene Targeting. We produced knockout mice in which neudesin was absent in the whole body. 
Briefly, exons 2 and 3 of neudesin, which code the cytochrome b5-like heme/steroid-binding domain22, 
were deleted by targeting vectors including the neomycin resistance sequence. neudesin KO mice were 
created via the homologous recombinant ES cells of C57BL/6J mice. Male chimeras were mated with 
C57BL/6J female mice to obtain F1 neudesin+/− mice. neudesin+/− mice were maintained on a C57BL/6 
background. Male and female neudesin+/− mice were intercrossed to obtain WT and neudesin−/− (neudesin 
KO) littermates. The genotypes of these mice were determined by polymerase chain reaction (PCR) using 
the following primers: P1 (5’-tttatggacgaggagccccctaca-3’), P2 (5’-agcgaaggagcaaagctgctattg-3’), and P3 
(5’-ggccatcctggtctacctagaaat-3’). P1 and P3 produced a 229-bp fragment of the WT neudesin locus. P2 
and P3 produced a 526-bp fragment of the mutant neudesin locus.
Animal Experiments. All mice were maintained in a light-controlled room (lights on from 0800 
to 2000 h). WT and neudesin KO mice were allowed free access to a normal diet (MF; 3.6 kcal/g, 12% 
kcal fat, source: soybean; Oriental Yeast, Tokyo, Japan) or high-fat diet (HFD; 5.24 kcal/g, 60% kcal 
fat, Research Diet, Inc., New Jersey, USA). The HFD-feeding experiments began at 4 weeks of age. All 
experiments were performed using male mice. Mice were weighed weekly and sacrificed to obtain tis-
sues and plasma samples at 16 weeks of age. All animal studies were conducted in accordance with 
the International Guiding Principles for Biomedical Research Involving Animals, and approved by the 
Animal Research Committee of Kyoto University Graduate School of Pharmaceutical Sciences.
RNA Isolation and Real-Time Quantitative RT-PCR. Total RNA was extracted from mouse tis-
sues at 16 weeks of age using an RNeasy minikit (QIAGEN, Hilden, Germany). cDNA was synthe-
sized from total RNA (1 μg) in a reaction mixture containing Moloney murine leukemia virus reverse 
transcriptase (Life Technologies, Maryland, USA) and a random hexadeoxynucleotide primer (Takara, 
Shiga, Japan). A quantitative RT-PCR (qRT-PCR) analysis was performed using a Thermal Cycler Dice 
(Takara) using SYBR qPCR Mix (TOYOBO, Osaka, Japan). 18S rRNA levels were determined as an 
internal control. The primers used were 5’-agggagtggtgttcgatgtc-3’ and 5’-agccaacaatggggtact-3’ for neu-
desin, 5’-catcagccatgtgggtacag-3’ and 5’-agtgtaggaatcccgcaatg-3’ for F4/80, 5’-tgcctggcagatatcatcac-3’ 
and 5’-cagtttcggcaatccttctg-3’ for Ucp1, 5’-ccttccagtacaagcacggt-3’ and 5’-tgggtagcatagaggccctt-3’ for 
Th, 5’-aagagcgccgtgtgatttac-3’ and 5’-ccatcatcccgcagatttac-3’ for Pgc-1α, 5’-aatgcaattcgctttggaag-3’ and 
5’-ggccttgaccttgttcatgt-3’ for Pparα, 5’-aggcctcgatgacaagaatg-3’ and 5’-ttccggaagagatcttggag-3’for Cpt1b, 
5’-aagctacacgatgccatgtc-3’ and 5’-tctgtccctgtctgctgtttc-3’ for β3AR, 5’-gacacgtggaagatgccgag-3’ and 
5’-cagcgagaggtcgagtttgc-3’ for Pomc, 5’-atgctgactgcaatgttgctg-3’ and 5’-cagacttagacctgggaactct-3’ for 
Agrp, 5’-aggcttgaagacccttccatg-3’ and 5’-gggtggaaacttggaaaagtcg-3’ for Npy, 5’-agagcagctgccttgatgtt-3’ 
and 5’-gtcgtcagacctctctcgaacc-3’ for Bdnf, 5’-gcagttagctcagcaagctcac-3’ and 5’-caaatgatatcggagctgcg-3’ for 
Crf and 5’-cgaacgtctgccctatcaactt-3’ and 5’-ccggaatcgaaccctgatt-3’ for 18S rRNA24,40,41.
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Histological Analysis. The WAT and BAT of WT and neudesin KO mice at 16 weeks of age were fixed 
in Bouin’s fixative, dehydrated, embedded in paraffin, and sectioned. Sections (8μm) were stained with 
hematoxylin and eosin, and examined by light microscopy. Images of WAT sections were captured and 
adipocyte sizes were measured for at least 100 cells per mouse with Image J software (National Institutes 
of Health, Maryland, USA).
The unfixed livers of WT and neudesin KO mice at 16 weeks of age were frozen in optimum cutting 
temperature compound (Sakura Finetek, Tokyo, Japan). Frozen sections (16μm) were stained with hema-
toxylin and eosin.
Biochemical Analysis. Blood glucose levels were measured with a Glutest R kit (Sanwa Kagaku 
Kenkyusho, Nagoya, Japan). Plasma insulin levels were measured using a mouse insulin ELISA kit 
(Morinaga, Tokyo, Japan). Plasma TG, non-esterified free fatty acid (NEFA), and total cholesterol levels 
were measured using the TG E-test, NEFA C-test, and cholesterol E-test (Wako, Osaka, Japan), respec-
tively. Plasma leptin levels were measured using a mouse leptin ELISA kit (Morinaga). Norepinephrine, 
epinephrine, and dopamine levels in plasma, WAT, and BAT were measured by HPLC, as described 
previously29,42.
Glucose Tolerance and Insulin Tolerance Tests. The glucose tolerance and insulin tolerance tests 
were performed at 16 weeks of age by an intraperitoneal injection of glucose (1.5 mg/g) or human regular 
insulin (1 units/kg) (MP Biomedicals, Ohio, USA) after 6 h of fasting. Blood samples were taken at dif-
ferent time points from a tail vein. Blood glucose and plasma insulin levels were measured, as described 
above.
Measurement of Food Intake. Daily food intakes by WT and neudesin KO mice were measured at 
16 weeks of age. The measurement of food intake was performed for 3 days and the average of 3 days 
was used in the analysis.
Measurement of fecal TG levels. Fecal lipids were extracted from dried feces (50 mg) of WT and 
neudesin KO mice at 8 weeks of age using the Folch method and fecal triglyceride (TG) levels were 
measured using TG E-test.
Respiratory Gas Analysis. Oxygen consumption by WT and neudesin KO mice was measured at 
12 weeks of age with an indirect calorimetric system. Briefly, room air was pumped through an acrylic 
metabolic chamber, and subjected to gas analysis (model ARCO-2000; Arco System, Tokyo, Japan). The 
respiratory quotient, fatty acid oxidation, and carbohydrate oxidation were calculated based on O2 con-
sumption and CO2 production43.
Measurement of Heart Rates. Heart rates were measured in conscious mice at 16 weeks of age 
using a tail-cuff system (Softron, Tokyo, Japan)29. Heart rates were measured daily for at least 3 days and 
the average of the 3 days was used in the analysis.
Production of Recombinant Mouse neudesin Protein. A recombinant neudesin protein was 
obtained as described previously18. Briefly, High Five cells infected with a recombinant baculovirus con-
taining neudesin cDNA with His6 tag at the 3’ terminus of the coding region were cultured at 27 °C for 
96 hr in Grace’s Insect Medium (Gibco, Rockville, MD, USA) with 10% fetal bovine serum (FBS). A 
recombinant neudesin protein was purified from the culture medium by affinity chromatography using 
Ni-NTA agarose (QIAGEN).
Cultures of PC12 Cells. PC12 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
(Gibco) supplemented with 10% horse serum (Gibco), 5% FBS, and 1% penicillin-streptomycin (Nacalai 
Tesque, Kyoto, Japan) at 37 °C. PC12 cells were seeded at 4.0 × 104 cells/well on 24-well plates. Medium 
was replaced on the next day at the beginning of the culture, and NGF (50 ng/ml; alomone labs, 
Jerusalem, Israel) in DMEM supplemented with 1% FBS and 1% penicillin-streptomycin was added. 
NGF was removed 24 hrs later and recombinant neudesin in DMEM supplemented with 1% FBS and 
1% penicillin-storeptomycin was added. Cells were collected 6hrs later and total RNA was extracted. The 
expression levels of Th were examined by qRT-PCR as described above.
Measurement of Lipolytic Activity. The subcutaneous WAT of WT and neudesin KO mice at 16 
weeks of age was homogenized in homogenizing buffer (50 mM Tris-HCl, pH8.0, 0.25 M sucrose, 1 mM 
EDTA, and 1% Protease Inhibitor Cocktail (Sigma-Aldrich, St. Louis, USA). Cell debris was removed by 
centrifugation at 1,000 g for 15 min to obtain cell extracts. The protein concentration in tissue extracts 
was determined using the Bio-Rad protein assay kit (Bio-Rad Laboratories, California, USA) with 
bovine serum albumin as the standard. The lipolytic activity of tissue extracts was determined using 
p-nitrophenyl laurate as the substrate44,45.
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Statistical Analysis. Data are expressed as means ± standard error of means (SEMs). The significance 
of differences in mean values was assessed with the Student’s t-test when two groups were analyzed. 
When more than two groups were compared, an analysis of variance was used to evaluate significant 
differences among groups, and if significant differences were confirmed, each difference was further 
examined by the Tukey-Kramer method. P < 0.05 was considered significant. GraphPad Prism6 was used 
for statistical analyse.
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